1. Home
  2. CPRX vs WSFS Comparison

CPRX vs WSFS Comparison

Compare CPRX & WSFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • WSFS
  • Stock Information
  • Founded
  • CPRX 2002
  • WSFS 1980
  • Country
  • CPRX United States
  • WSFS United States
  • Employees
  • CPRX N/A
  • WSFS N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • WSFS Major Banks
  • Sector
  • CPRX Health Care
  • WSFS Finance
  • Exchange
  • CPRX Nasdaq
  • WSFS Nasdaq
  • Market Cap
  • CPRX 2.9B
  • WSFS 2.7B
  • IPO Year
  • CPRX 2006
  • WSFS N/A
  • Fundamental
  • Price
  • CPRX $24.86
  • WSFS $52.42
  • Analyst Decision
  • CPRX Strong Buy
  • WSFS Hold
  • Analyst Count
  • CPRX 7
  • WSFS 4
  • Target Price
  • CPRX $32.29
  • WSFS $61.00
  • AVG Volume (30 Days)
  • CPRX 1.1M
  • WSFS 307.2K
  • Earning Date
  • CPRX 05-07-2025
  • WSFS 07-24-2025
  • Dividend Yield
  • CPRX N/A
  • WSFS 1.29%
  • EPS Growth
  • CPRX 178.13
  • WSFS N/A
  • EPS
  • CPRX 1.57
  • WSFS 4.44
  • Revenue
  • CPRX $534,645,999.00
  • WSFS $987,714,000.00
  • Revenue This Year
  • CPRX $16.37
  • WSFS N/A
  • Revenue Next Year
  • CPRX $8.80
  • WSFS $3.45
  • P/E Ratio
  • CPRX $15.91
  • WSFS $11.91
  • Revenue Growth
  • CPRX 29.97
  • WSFS 4.38
  • 52 Week Low
  • CPRX $14.75
  • WSFS $42.21
  • 52 Week High
  • CPRX $26.16
  • WSFS $62.75
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 61.03
  • WSFS 44.10
  • Support Level
  • CPRX $24.19
  • WSFS $51.75
  • Resistance Level
  • CPRX $25.00
  • WSFS $54.22
  • Average True Range (ATR)
  • CPRX 0.68
  • WSFS 1.32
  • MACD
  • CPRX 0.07
  • WSFS -0.36
  • Stochastic Oscillator
  • CPRX 90.18
  • WSFS 3.99

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

About WSFS WSFS Financial Corporation

WSFS Financial Corp is a savings and loan holding company. The company operates in three segments: WSFS Bank provides loans and leases and other financial products to commercial and consumer customers. Cash Connect segment provides ATM vault cash, smart safe, and other cash logistics services; and Wealth Management provides a broad array of planning and advisor services, investment management, personal and institutional trust services, and credit and deposit products to individuals, corporate, and institutional clients. Majority revenue is generated from WSFS Bank segment.

Share on Social Networks: